A prospective longitudinal study of Pasireotide in Nelson's syndrome.
Trainer, Peter J
AffiliationDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK
MetadataShow full item record
AbstractNelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma ACTH and tumor volume in Nelson's syndrome.
CitationA prospective longitudinal study of Pasireotide in Nelson's syndrome. 2018 Pituitary